A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )

Clinical trial NCT02059642 · COMPLETED

Trial details

NCT number: NCT02059642
Sponsor: Alcobra Ltd.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

ADHD Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type

Start date: 2014-03-01
Primary completion: 2014-09-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.